Showing 35,225 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

PrEP policies & guidelines

CDC: Tell Everyone About HIV PrEP and Don't 'Grill' Patients

Editor's pick
Medscape (requires free registration)
9 December 2021
Finance & funding

HIV Prevention R&D Funding Drops Again, Even as Major Scientific Advances Require Support

Editor's pick
AVAC
9 December 2021
Injectable & long-acting HIV treatment

The Medicines Patent Pool and the University of Washington sign a licence agreement for an investigational long-acting injectable drug combination candidate for HIV

Editor's pick
Medicines Patent Pool
9 December 2021
Adherence

Digital pill tracks HIV prevention pill adherence with 98 percent accuracy

Editor's pick
European Pharmaceutical Review
9 December 2021
Coronavirus

People living with HIV, regardless of CD4 count or viral load, more likely to experience COVID-19 breakthrough infections

News
8 December 2021

England surpasses global targets for HIV – HIV update, 8 December 2021

December 2021
PrEP programmes & uptake

Practitioners and policies create barriers to PrEP and HIV testing for young people in sub-Saharan Africa

News
8 December 2021
Drug policy & policing

English government announces ‘largest ever’ increase in drug treatment funding

Editor's pick
Drink and Drugs News
7 December 2021
HIV treatment

Doctors Keep Telling Me to Chuck My Longtime HIV Regimen. I’m Not—and Here’s Why

Editor's pick
TheBody
7 December 2021
Pharmaceutical industry

Merck pauses 2 more trials of backbone HIV drug over red flag, raising doubts about multi-pronged R&D strategy

Editor's pick
FierceBiotech
7 December 2021
Malaria

COVID contributed to 69,000 malaria deaths WHO finds, though ‘doomsday scenario’ averted

Editor's pick
UN News
7 December 2021
Treatment outcomes & life expectancy

Susan Cole talks about life expectancy for people living with HIV Video

December 2021
PrEP science

Merck Announces Pause in Enrollment for Two Phase 3 Clinical Trials of Investigational, Once-Monthly, Oral Islatravir for Pre-Exposure Prophylaxis (PrEP) of HIV-1 infection

Editor's pick
BusinessWire
7 December 2021
Hepatitis C transmission & prevention

Australia on track to eliminate hepatitis C among gay and bisexual men before 2030

News
7 December 2021
The biology of HIV transmission

Matthew Hodson talks about HIV transmission Video

December 2021
Government, leadership & policy

US: What’s New in the Updated National HIV/AIDS Strategy?

Editor's pick
POZ
6 December 2021
Government, leadership & policy

Fauci: Steadfast Focus on HIV Disparities Needed

Editor's pick
Medscape (requires free registration)
6 December 2021
Treatment guidelines

Community Position Statement: DRV/r Must Urgently Become the Preferred Protease Inhibitor Used in Adult Second-Line ART

Editor's pick
AfroCAB
6 December 2021
Global health targets

Africa cuts HIV infections, deaths but key targets still elusive

Editor's pick
World Health Organization
6 December 2021
PrEP programmes & uptake

Israeli Gays Fought for Subsidy of an anti-HIV Drug. Why Are So Few Using It?

Editor's pick
Haaretz
6 December 2021
The search for a cure

HIV genes can successfully be removed from cells, scientists find

News
6 December 2021
HIV in the arts & media

Stigma of HIV and representations in the media

Editor's pick
Patient
3 December 2021
Treatment outcomes & life expectancy

About 35,000 HIV patients die in Russia every year, expert says

Editor's pick
TASS
3 December 2021
HIV in the arts & media

Gripping series celebrates the unsung heroes and untold stories of Britain’s HIV epidemic

Editor's pick
Pink News
3 December 2021